基于英国生物样本库的心血管健康与新发年龄相关性黄斑变性的关联
该纵向分析纳入271274名基线无心血管疾病和年龄相关性黄斑变性(AMD)的参与者,用生命必需8(LE8)评分评估心血管健康(CVH)。平均随访10.9年期间记录7468例(2.8%)AMD;中、高CVH水平分别与AMD风险降低14%(HR=0.86;95%CI 0.78-0.94)和23%(HR=0.77;95%CI 0.69-0.86)相关,LE8评分与AMD发病率呈线性剂量反应关系。
要点
- 中CVH水平(LE8评分50至<80分)与AMD风险降低14%相关(HR=0.86;95%CI 0.78-0.94)。
- 高CVH水平(LE8评分≥80分)与AMD风险降低23%相关(HR=0.77;95%CI 0.69-0.86)。
- 所有人达到最佳CVH可能预防9.4%的AMD病例(95%CI 3.7%-15.1%)。
核心结论
- 增强CVH与新发AMD风险降低显著相关。
- 通过LE8指南促进CVH可能有助于预防AMD。
研究设计与样本
- 纵向分析,纳入271274名基线无心血管疾病和AMD的参与者。
- LE8评分分为低(<50分)、中(50至<80分)、高(≥80分)三类,评分越高表示CVH越好。
- 采用Cox比例风险模型分析CVH与AMD发病率的关系,并计算CVH及各单项指标的归因危险度百分比(PAR%)。
主要发现
- 平均随访10.9年期间共记录7468例(2.8%)AMD。
- 中CVH水平者AMD风险降低14%(HR=0.86;95%CI 0.78-0.94)。
- 高CVH水平者AMD风险降低23%(HR=0.77;95%CI 0.69-0.86)。
- 累积LE8评分与AMD发病率之间呈线性剂量反应关系。
- 所有人达到最佳CVH可能预防9.4%的AMD病例(95%CI 3.7%-15.1%)。
关键数值与推荐
- LE8评分低为<50分,中为50至<80分,高为≥80分,评分越高表示CVH越好。
- 中CVH水平:HR=0.86(95%CI 0.78-0.94)。
- 高CVH水平:HR=0.77(95%CI 0.69-0.86)。
- 所有人达到最佳CVH可能预防9.4%的AMD病例(95%CI 3.7%-15.1%)。
- 理想血糖水平与AMD病例减少3.3%相关,理想血压水平与AMD病例减少8.7%相关。
临床怎么用
- 原文结论认为通过LE8指南促进CVH可能有助于预防AMD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the correlation between cardiovascular health (CVH), evaluated through the Life's Essential 8 (LE8) score, and the risk of new-onset age-related macular degeneration (AMD). METHODS: This longitudinal analysis included 271,274 participants who were free of both cardiovascular diseases and AMD at baseline. The LE8 score was classified into three categories: low (<50 points), moderate (50 to <80 points), and high (≥80 points), with higher scores indicating better CVH. Cox proportional hazards models were used to explore the relationships between the CVH and AMD incidence. Furthermore, the population attributable risk (PAR%) was calculated for CVH and each individual metric. RESULTS: During an average follow-up duration of 10.9 years, a total of 7468 (2.8%) cases of AMD were documented. Individuals with moderate and high CVH levels had a 14% (hazard ratio [HR] = 0.86; 95% confidence interval [CI], 0.78-0.94) and 23% (HR = 0.77; 95% CI, 0.69-0.86) reduced risk of developing AMD, respectively. A linear dose-response relationship was identified between the cumulative LE8 score and the incidence of AMD. Attaining optimal CVH in all individuals could potentially avert 9.4% (95% CI, 3.7%-15.1%) of AMD cases. Among the CVH metrics, ideal blood glucose and blood pressure levels were related to a reduction of 3.3% and 8.7% in AMD cases, respectively. CONCLUSIONS: Enhanced CVH is significantly associated with a reduced risk of developing AMD. Promoting CVH through the LE8 guideline might potentially contribute to the prevention of AMD.
引用
- Peng Y, Zhang Y, Kam KW, et al. Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank. Invest Ophthalmol Vis Sci. 2025. PMID: 40261662. doi:10.1167/iovs.66.4.63
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。